Sufentanil is a strong synthetic opioid analgesic that has been used as an anesthetic agent. Research has evaluated the effects of an intranasal formulation of sufentanil as a treatment for cancer-related breakthrough pain. At the time of this writing, this formulation is not yet FDA-approved for use in the United States. Sufentanil for injection is also available.